We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

BNP Guided Care in Addition to Multidisciplinary Care

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00355017
Recruitment Status : Terminated
First Posted : July 20, 2006
Last Update Posted : October 18, 2006
Information provided by:
Medical University of Vienna

Brief Summary:

HF is associated with repeated hospitalisations and poor prognosis.The aim of this study is to investigate whether BNP-guided care (BGC) in addition to multidisciplinary management(MM) improves outcome compared to HNC alone or usual care (UC) for decompensated HF patients after discharge.

Patients hospitalised with cardiac decompensation in 9 Viennese hospitals are randomised to BGC, MM alone, or UC. MM includes 2 consultations of a heart failure (HF) specialist 10 days and 2 months after discharge for recommending medical optimisation and care by a specialised HF nurse including 4 home visits and telephone contact. In addition, BGC includes intensified increase of medical treatment during repeated follow-up visits in a HF clinic in patients with an Nt-BNP level above 2200pg/ml at discharge.

Condition or disease Intervention/treatment
Decompensated Heart Failure Procedure: BNP-guided care in addition to multidisciplinary management

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: NT-BNP Guided Care in Addition to Multidisciplinary Care in Patients With Chronic Heart Failure A Three-Arm, Prospective, Randomised Study
Study Start Date : September 2003
Estimated Study Completion Date : September 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Failure
U.S. FDA Resources

Primary Outcome Measures :
  1. Heart failure rehospitalisation rate;
  2. combined endpoint death or heart failure rehospitalisation;

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   19 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. Clinical signs and symptoms of cardiac decompensation during the present hospitalisation
  2. NYHA class III or IV at time of admission
  3. Cardiothoracic ratio > 0.5, and/or left ventricular ejection fraction <40% documented by echocardiography

Exclusion Criteria:

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00355017

Sponsors and Collaborators
Medical University of Vienna
Principal Investigator: Richard Pacher, MD Medical University of Vienna

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00355017     History of Changes
Other Study ID Numbers: VF: 05.05.2003
First Posted: July 20, 2006    Key Record Dates
Last Update Posted: October 18, 2006
Last Verified: July 2006

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases